1-7 of 7
Yuhong Ren
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-world outcomes of glofitamab-based regimens in relapsed/refractory aggressive B-cell lymphoma

Free
Yuhong Ren, Yang Ke, Zhixiang Cheng, Ling Yuan, Weiguang Wang, Jingli Zhuang, Luya Cheng, Yue Wang, Jiadai Xu, Xuejiao Zhang, Jing Li, Peng Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 7257.
https://doi.org/10.1182/blood-2025-7257
Published: 2025
Journal Articles

Pola-R-CHP in previously untreated low-risk (IPI 0-1) DLBCL: A nationwide multicenter retrospective study in China

Free
Yuhong Ren, Jia Liu, Zhijuan Lin, Lihong Shou, Hui Zeng, Dong Wu, Zhiyong Zeng, Fengping Zhou, Li Bao, Hongmei Jing, Songfu Jiang, Haisheng Liu, Jianzhen Shen, Wenjuan Yu, Hui Zhou, Jingyan Xu, Yan Zhang, Ting Wang, Honghui Huang, Bing Xu, Peng Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 7229.
https://doi.org/10.1182/blood-2025-7229
Published: 2025
Journal Articles

An exploratory study to evaluate the safety and efficacy of autologous CAR-T cells with dual targeting of BCMA and CD19 (FKC289 Injection) in subjects with relapsed or refractory systemic light chain amyloidosis

Free
Jing Li, Shiyang Gu, Yuhong Ren, Yang Yang, Jiadai Xu, Yian Zhang, Tianhong Xu, Xiaochen Wang, Xiaojiao Zhao, He Xin, Zisong Zhou, Peng Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 7674.
https://doi.org/10.1182/blood-2025-7674
Published: 2025
Journal Articles

Pola-R-CHP in newly diagnosed primary mediastinal B-cell lymphoma:high efficacy and tolerability

Free
Xue Yang, Yuhong Ren, Luya Cheng, Peng Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 3682.
https://doi.org/10.1182/blood-2025-3682
Published: 2025
Journal Articles

Phase 2 Study of polatuzumab vedotin, zanubrutinib and rituximab (Pola-ZR) in untreated elderly and frail DLBCL patients: Molecular features and follow-up updates

Free
Yuhong Ren, Jing Li, Zhixiang Cheng, Jingli Zhuang, Hui Tan, Luya Cheng, Ling Yuan, Yang Ke, Peng Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 1917.
https://doi.org/10.1182/blood-2025-1917
Published: 2025
Journal Articles

Polatuzumab Vedotin, Zanubrutinib and Rituximab Achieved Rapid and Deep Response in Previously Untreated Frail and Elderly Diffuse Large B-Cell Lymphoma Patients

Free
Yuhong Ren, Jingli Zhuang, Ling Yuan, Lili Ji, Yang Ke, Peng Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 1747.
https://doi.org/10.1182/blood-2023-186170
Published: 2023
Journal Articles

Retinoic Acid and Arsenic Trioxide with or without Chemotherapy for Acute Promyelocytie Leukemia with Different Risk Stratifications: A Interim Analysis of China APL 2012 Study

Free
Junmin Li, Prof., Li Chen, Hongming Zhu, Jiong Hu, PhD/MD, Bing Chen, Xiaoyang Li, Lining Wang, Yunxiang Zhang, Yuhong Ren, Huijin Zhao, Yu Chen, Huiping Sun, Qiusheng Chen, Yu Chen, Weili Zhao, MD PhD, Jianqing Mi, Zhixiang Shen, MD, Zhenyi Wang, Zhu Chen, Saijuan Chen
Journal: Blood
Blood (2016) 128 (22): 445.
https://doi.org/10.1182/blood.V128.22.445.445
Published: 2016